Strategic Development Partnership between Farfield Scientific and Monash University
News Jun 21, 2007
Farfield Scientific Limited and the Department of Biochemistry and Molecular Biology at Monash University have recently entered a strategic partnership to create a series of biosensor surfaces that will be used to establish a new approach to the structural analysis of membrane protein function.
The partnership has recently attracted Australian Research Council funding at Monash. The aim of the collaboration is to commercialise a new generation of membrane-mimetic biosensor surfaces which can be used to analyse the structure and function of membrane-associating peptides and proteins.
Dr Gerry Ronan, CEO at Farfield Scientific said, "Dr Aguilar’s research into membrane proteins is internationally renowned and we are delighted that she has chosen to undertake this work with her AnaLight® facility. Membrane proteins are the subject of intense academic and commercial interest as they are the gateways to the cell but they are notoriously difficult to study."
Dr. Ronan continued, "This collaboration will deliver a bioanalytical toolkit which will transform the life scientist’s ability to unravel the mechanisms by which these proteins function and will ultimately lead to an entirely new approach to structurally informed drug discovery."
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019